By: Pat Anson, PNN Editor 7/26/19 The U.S. Food and Drug Administration is tapping the brakes on NKTR-181, an experimental opioid pain medication that has less abuse potential than traditional opioids like oxycodone or hydrocodone. In an SEC filing, Nektar Therapeutics said it received a letter from the FDA on July 23 saying the agency…
Tag: Pat Anson
Pain News Network’s (PNN) Post from 9/14/16
Good Afternoon from Sunny California, Today (September 14, 2016 at 4:03 pm PST, Pain News Network (PNN) sent the following email to their subscribers. I wanted to show all of you that your voice does matter, without you letting others know what’s important about you and your pain some if not all of this would…
iCareTalk.net 